Streetbeat News

Stock Prices

PEP

PepsiCo's short interest has increased by 11.48%, with 18.72 million shares sold short, representing 1.36% of its float. This is lower than the peer group average of 7.30%. The rise in short interest may indicate bearish sentiment, but it doesn't guarantee a price drop.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 4:15 pm

CSLR

Complete Solaria shares rose after winning a bid in the SunPower Chapter 11 proceedings.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:12 pm

HYZN

Hyzon Motors shares rose as the company began production of its Class 8 200kW fuel cell electric trucks.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:11 pm

GRDN

Guardian Pharmacy Services has announced its initial public offering (IPO) of 6.75 million shares priced between $14 and $16 per share. The shares will be listed on the NYSE under the symbol 'GRDN'. The company has also granted underwriters a 30-day option to purchase an additional 1,012,500 shares.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:08 pm

SIRI

Rosenblatt analyst Barton Crockett maintains a Neutral rating on Sirius XM Holdings and adjusts the price target to $28 from $3.4, reflecting a 1:10 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:08 pm

CACI

CACI International, Inc. (NYSE:CACI) is acquiring Azure Summit Technology for $1.275 billion to enhance its defense capabilities, particularly in RF technology. The acquisition is expected to provide a $194 million tax benefit over 15 years. CACI shares rose 3.18% following the announcement.

Portfolio Pulse from Lekha Gupta

September 16, 2024 | 4:06 pm

IPA

ImmunoPrecise Antibodies shares declined following the release of disappointing Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

September 16, 2024 | 4:03 pm

PARR

Par Pacific Holdings (NYSE:PARR) has received mixed analyst ratings over the past quarter, with a decrease in the average 12-month price target from $37.17 to $32.29. Analysts have lowered their ratings and price targets, reflecting cautious sentiment. Despite positive revenue growth and strong financial metrics, concerns about high debt levels persist.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 4:01 pm

DOC

In the past three months, analysts have shown a positive shift in sentiment towards Healthpeak Properties (NYSE:DOC), with several raising their price targets. The average 12-month price target increased by 8.07% to $24.5. Healthpeak Properties has demonstrated strong financial performance, with significant revenue growth and profitability metrics exceeding industry averages.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 4:00 pm

KRC

Analysts have recently evaluated Kilroy Realty (NYSE:KRC), showing a range of sentiments from somewhat bullish to indifferent. The average 12-month price target has decreased by 3.07% to $39.5. Analysts have adjusted their ratings and price targets, reflecting a negative shift in sentiment. Despite a revenue decline, Kilroy Realty maintains strong financial metrics, including a high net margin and efficient debt management.

Portfolio Pulse from Benzinga Insights

September 16, 2024 | 4:00 pm